Top-News
Krebsforschung USA

Cardiff Oncology News

Aktie
WKN:  A2P4GU ISIN:  US14147L1089 US-Symbol:  CRDF
3,445 €
-0,025 €
-0,72%
07:35:03 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
44,68 Mio.
Marktkapitalisierung *
153,77 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 28.06.2023

Cardiff Oncology News

26.03.24 - PR Newswire
Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics?
Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics? PR Newswire
15.03.24 - PR Newswire
Thinking about buying stock in Mind Medicine, Ocean Biomedical, Archer Aviation, Outlook Therapeutics, or Cardiff Oncology?
Thinking about buying stock in Mind Medicine, Ocean Biomedical, Archer Aviation, Outlook Therapeutics, or Cardiff Oncology? PR Newswire
14.03.24 - PR Newswire
Thinking about buying stock in SoundHound AI, Kinross Gold, Nu Holdings, Cardiff Oncology, or Turtle Beach?
Thinking about buying stock in SoundHound AI, Kinross Gold, Nu Holdings, Cardiff Oncology, or Turtle Beach? PR Newswire
13.03.24 - PR Newswire
Thinking about buying stock in ShiftPixy, Minim, Cardiff Oncology, Laird Superfood, or Tenon Medical?
Thinking about buying stock in ShiftPixy, Minim, Cardiff Oncology, Laird Superfood, or Tenon Medical? PR Newswire
11.03.24 - PR Newswire
Thinking about buying stock in Recursion Pharmaceuticals, SoundHound AI, Cardiff Oncology, Mind Medicine, or Auddia?
Thinking about buying stock in Recursion Pharmaceuticals, SoundHound AI, Cardiff Oncology, Mind Medicine, or Auddia? PR Newswire
08.03.24 - PR Newswire
Thinking about buying stock in SoundHound AI, Gulf Island Fabrication, Macy's, Rigetti Computing, or Cardiff Oncology?
Thinking about buying stock in SoundHound AI, Gulf Island Fabrication, Macy's, Rigetti Computing, or Cardiff Oncology? PR Newswire
17.01.24 - PR Newswire
Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research
Cardiff Oncology Announces Publication of Data from Phase 1b study in second-​line KRAS-​mutated mCRC in Clinical Cancer Research PR Newswire
20.11.23 - PR Newswire
Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference
Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference PR Newswire
02.11.23 - PR Newswire
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update PR Newswire
26.10.23 - PR Newswire
Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update
Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update PR Newswire
26.09.23 - PR Newswire
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-​Agent Activity from Onvansertib Monotherapy PR Newswire
05.09.23 - PR Newswire
Cardiff Oncology to Present at Upcoming Investor Conferences in September
Cardiff Oncology to Present at Upcoming Investor Conferences in September PR Newswire
09.08.23 - PR Newswire
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update PR Newswire
07.08.23 - PR Newswire
Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship
Cardiff Oncology Announces New Lead Program in First-​Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship PR Newswire
24.07.23 - PR Newswire
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
20.06.23 - PR Newswire
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
05.06.23 - PR Newswire
Cardiff Oncology to Present at the Jefferies Healthcare Conference
Cardiff Oncology to Present at the Jefferies Healthcare Conference PR Newswire
04.05.23 - PR Newswire
Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
Cardiff Oncology Reports First-​Quarter 2023 Results and Provides Business Update PR Newswire
28.03.23 - PR Newswire
Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal Cancer
Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal Cancer PR Newswire
06.03.23 - PR Newswire
Cardiff Oncology Formally Introduces Scientific Advisory Board
Cardiff Oncology Formally Introduces Scientific Advisory Board PR Newswire

Newssuche

Videos

newspaper
14.05.24 -16,04%
Technical Trading: DAX dienstags Long
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »